|4Oct 14, 8:40 PM ET

Fu Tao 4

4 · Zai Lab Ltd · Filed Oct 14, 2021

Insider Transaction Report

Form 4
Period: 2021-10-14
Fu Tao
DirectorPresident & COO
Transactions
  • Sale

    Ordinary Shares

    2021-10-14$102.02/sh3,360$342,78794,140 total(indirect: See footnote)
  • Sale

    Ordinary Shares

    2021-10-14$102.90/sh5,240$539,19688,900 total(indirect: See footnote)
  • Sale

    Ordinary Shares

    2021-10-14$103.44/sh1,400$144,81687,500 total(indirect: See footnote)
Holdings
  • Ordinary Shares

    187,668
Footnotes (5)
  • [F1]The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person's spouse, dated June 17, 2021, expires February 28, 2022 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
  • [F2]Reflects a weighted average sale price of $102.02 per share, at prices ranging from $101.40 to $102.27 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  • [F3]Reflects a weighted average sale price of $102.90 per share, at prices ranging from $102.42 to $103.38 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  • [F4]Reflects a weighted average sale price of $103.44 per share, at prices ranging from $103.43 to $103.50 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  • [F5]Shares held by Reporting Person's spouse.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4